![Søren Bregenholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Bregenholt
Verkställande Direktör på
ALLIGATOR BIOSCIENCE AB
Profil
Søren Bregenholt currently works at Alligator Bioscience AB, as Chief Executive Officer from 2021, Medicon Valley Alliance FMBA, as Chairman, A Bioscience Incentive AB, as Chairman, Atlas Therapeutics AB, as Chairman, and Oblique Therapeutics AB, as Director.
Dr. Bregenholt also formerly worked at Macrophage Pharma Ltd., as Chief Executive Officer & Director, Novo Nordisk A, as Investment Manager, and Symphogen A, as Chief Operating Officer.
Dr. Bregenholt received his doctorate degree from the University of Copenhagen.
Senaste nyheterna om Søren Bregenholt
Aktiva positioner av Søren Bregenholt
| Företag | Position | Start |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Verkställande Direktör | 2021-06-01 |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Ordförande | - |
A Bioscience Incentive AB | Ordförande | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Ordförande | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Søren Bregenholt
| Företag | Position | Slut |
|---|---|---|
| NOVO NORDISK A/S | Chef för investeringar | - |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Verkställande Direktör | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Verksamhetschef | - |
Søren Bregenholts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Medicon Valley Alliance FMBA
Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Commercial Services |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
A Bioscience Incentive AB | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
